Literature DB >> 24972668

The placebo effect is a relevant factor in evaluating effectiveness of therapies in functional gastrointestinal disorders.

Edoardo Savarino1, Chiara De Cassan, Giorgia Bodini, Manuele Furnari, Nicola de Bortoli, Vincenzo Savarino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24972668     DOI： 10.1007/s00535-014-0974-7

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  14 in total

Review 1.  American gastroenterological association technical review on the evaluation of dyspepsia.

Authors:  Nicholas J Talley; Nimish B Vakil; Paul Moayyedi
Journal:  Gastroenterology       Date:  2005-11       Impact factor: 22.682

2.  Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials.

Authors:  S J Veldhuyzen van Zanten; C Cleary; N J Talley; T C Peterson; O Nyrén; L A Bradley; M Verlinden; G N Tytgat
Journal:  Am J Gastroenterol       Date:  1996-04       Impact factor: 10.864

3.  Overweight is a risk factor for both erosive and non-erosive reflux disease.

Authors:  Edoardo Savarino; Patrizia Zentilin; Elisa Marabotto; Daria Bonfanti; Simona Inferrera; Lorenzo Assandri; Giorgio Sammito; Lorenzo Gemignani; Manuele Furnari; Pietro Dulbecco; Vincenzo Savarino
Journal:  Dig Liver Dis       Date:  2011-09-22       Impact factor: 4.088

4.  Impedance-pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients.

Authors:  Edoardo Savarino; Patrizia Zentilin; Radu Tutuian; Daniel Pohl; Lorenzo Gemignani; Alberto Malesci; Vincenzo Savarino
Journal:  J Gastroenterol       Date:  2011-10-25       Impact factor: 7.527

5.  Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy.

Authors:  Edoardo Savarino; Radu Tutuian; Patrizia Zentilin; Pietro Dulbecco; Daniel Pohl; Elisa Marabotto; Andrea Parodi; Giorgio Sammito; Lorenzo Gemignani; Giorgia Bodini; Vincenzo Savarino
Journal:  Am J Gastroenterol       Date:  2009-12-08       Impact factor: 10.864

Review 6.  Functional esophageal disorders.

Authors:  Jean Paul Galmiche; Ray E Clouse; András Bálint; Ian J Cook; Peter J Kahrilas; William G Paterson; Andre J P M Smout
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

7.  Prevalence and symptom pattern of pathologic esophageal acid reflux in patients with functional dyspepsia based on the Rome III criteria.

Authors:  Ying-Lian Xiao; Sui Peng; Jin Tao; An-Jiang Wang; Jin-Kun Lin; Pin-Jin Hu; Min-Hu Chen
Journal:  Am J Gastroenterol       Date:  2010-09-07       Impact factor: 10.864

Review 8.  NERD: an umbrella term including heterogeneous subpopulations.

Authors:  Edoardo Savarino; Patrizia Zentilin; Vincenzo Savarino
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-26       Impact factor: 46.802

9.  Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn.

Authors:  Edoardo Savarino; Patrizia Zentilin; Luca Mastracci; Pietro Dulbecco; Elisa Marabotto; Lorenzo Gemignani; Luca Bruzzone; Nicola de Bortoli; Anna Chiara Frigo; Roberto Fiocca; Vincenzo Savarino
Journal:  J Gastroenterol       Date:  2012-09-25       Impact factor: 7.527

10.  Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease.

Authors:  E Savarino; D Pohl; P Zentilin; P Dulbecco; G Sammito; L Sconfienza; S Vigneri; G Camerini; R Tutuian; V Savarino
Journal:  Gut       Date:  2009-05-20       Impact factor: 23.059
View more
  1 in total

Review 1.  Placebo Responses and Placebo Effects in Functional Gastrointestinal Disorders.

Authors:  Paul Enck; Sibylle Klosterhalfen
Journal:  Front Psychiatry       Date:  2020-08-25       Impact factor: 4.157
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.